Skip to main content
July 22, 2020
Robin Carhart-Harris, PhD, head of the Centre of Psychedelic Research at Imperial College London in England, discusses the power of psychedelics.
March 19, 2020
Michael Thase, MD, of the University of Pennsylvania, discusses the use of second-generation antipsychotics as an adjunctive therapy in depression.
December 05, 2019
W. Clay Jackson, MD, DipTh, explains the difference between major depressive disorder and major depressive disorder with mixed features.
November 07, 2019
Sanjay J. Mathew, MD, speaks about best practices for administering esketamine during his Psych Congress 2019 presentation "Top 5 Issues Clinicians Should Know about Ketamine Therapy."
February 18, 2019
In this video, Marlene Freeman, MD, discusses tools for detecting postpartum depression, how postpartum depression differs from other mental health disorders, and risk factors for postpartum depression.
February 11, 2019
In this video, Mark Zimmerman, MD, discusses severe depression and how it differs from mild and moderate depression, and the signs and treatment of severe depression.
February 07, 2019
Psychedelics researcher Robin Carhart-Harris, PhD, who delivered the opening session at Psych Congress 2018, spoke about the compounds at the World Economic Forum Annual Meeting in Davos, Switzerland.
November 14, 2018
Marlene Freeman, MD, discusses her poster presented at Psych Congress 2018, "EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy." Poster and video sponsored by JayMac Pharmaceuticals, LLC.
March 22, 2018
Psych Congress cochair Charles Raison, MD, recently discussed his research and perspectives in an extensive interview with Rhonda Perciavalle Patrick, PhD, who runs the FoundMyFitness website.
July 24, 2017
Mary Kay Lobo, PhD, an assistant professor at the University of Maryland School of Medicine, Baltimore, explains research which suggests a specific gene, Slc6a15, may be central to depression.
Back to Top